| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
13,660,000 |
| Market
Cap: |
9.15(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.599 - $0.71 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lixte Biotechnology Holdings is a drug discovery company that uses biomarker technology to identify enzyme targets associated with common diseases and then designs compounds to attack those targets. Co.'s product pipeline is focused on inhibitors of protein phosphatases. Co. has developed two series of pharmacologically active drugs: the LB-100 series, which consists of structures that may be useful in the treatment of not only several types of cancer but also vascular and metabolic diseases; and the LB-200 series, which contains compounds that may be useful for the treatment of chronic hereditary diseases, such as Gaucher's disease, in addition to cancer and neurodegenerative diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
30,000 |
163,612 |
| Total Buy Value |
$0 |
$0 |
$76,232 |
$193,470 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
5 |
15 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Van Der Baan Bastiaan Jeroen |
President and CEO |
• • – |
2023-10-03 |
4 |
B |
$2.80 |
$28,000 |
D/D |
10,000 |
11,000 |
2.81 |
- |
|
| Bernards Rene |
Director |
– • – |
2023-10-03 |
4/A |
B |
$2.51 |
$13,873 |
D/D |
5,527 |
25,000 |
2.39 |
- |
|
| Bernards Rene |
Director |
– • – |
2023-10-03 |
4 |
B |
$2.51 |
$13,873 |
D/D |
5,527 |
0 |
2.39 |
- |
|
| Bernards Rene |
Director |
– • – |
2023-10-02 |
4/A |
B |
$2.29 |
$10,243 |
D/D |
4,473 |
19,473 |
2.39 |
- |
|
| Bernards Rene |
Director |
– • – |
2023-10-02 |
4 |
B |
$2.29 |
$10,243 |
D/D |
4,473 |
0 |
2.39 |
- |
|
| Van Der Baan Bastiaan Jeroen |
Director |
– • – |
2022-12-30 |
4 |
B |
$4.90 |
$49,000 |
D/D |
10,000 |
10,000 |
2.39 |
28% |
|
| Bernards Rene |
Director |
– • – |
2022-12-15 |
4 |
B |
$0.51 |
$7,650 |
D/D |
15,000 |
150,000 |
2.39 |
2% |
|
| Bernards Rene |
Director |
– • – |
2022-12-12 |
4 |
B |
$0.61 |
$6,100 |
D/D |
10,000 |
135,000 |
2.39 |
3% |
|
| Forman Eric |
Vice President and COO |
• – – |
2022-12-09 |
4 |
B |
$0.60 |
$9,836 |
I/I |
16,112 |
0 |
1.99 |
6% |
|
| Forman Eric |
Vice President and COO |
• – – |
2022-11-22 |
4 |
B |
$0.56 |
$1,391 |
I/I |
2,484 |
102,083 |
1.91 |
61% |
|
| Forman Eric |
Vice President and COO |
• – – |
2022-11-21 |
4 |
B |
$0.56 |
$816 |
I/I |
1,457 |
99,599 |
1.91 |
62% |
|
| Brown Regina |
Director |
– • – |
2022-11-21 |
4 |
B |
$0.57 |
$2,876 |
D/D |
5,000 |
6,300 |
2.31 |
62% |
|
| Forman Eric |
Vice President and COO |
• – – |
2022-11-18 |
4 |
B |
$0.56 |
$9,125 |
I/I |
16,207 |
98,142 |
1.99 |
47% |
|
| Forman Eric |
Vice President and COO |
• – – |
2022-11-17 |
4 |
B |
$0.54 |
$2,619 |
I/I |
4,852 |
81,935 |
1.91 |
53% |
|
| Bernards Rene |
Director |
– • – |
2022-11-14 |
4 |
B |
$0.53 |
$27,825 |
D/D |
52,500 |
125,000 |
2.39 |
41% |
|
| Bernards Rene |
Director |
– • – |
2022-06-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,500 |
|
-26% |
|
| Krinsky Glenn |
10% Owner |
– – • |
2021-12-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,333,333 |
|
-11% |
|
| Krinsky Glenn |
10% Owner |
– – • |
2021-12-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
141,665 |
|
-11% |
|
| Forman Eric |
Secretary |
• – – |
2021-12-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,333,333) |
38,598 |
|
- |
|
| Forman Eric |
Secretary |
• – • |
2021-04-22 |
4 |
OE |
$0.90 |
$15,000 |
D/D |
16,667 |
38,598 |
|
- |
|
| Forman Stephen J. |
Director |
– • – |
2021-04-22 |
4 |
OE |
$0.96 |
$32,001 |
D/D |
33,334 |
58,137 |
|
- |
|
| Palmedo Philip F |
Director |
– • – |
2021-04-22 |
4 |
OE |
$0.72 |
$54,000 |
D/D |
75,000 |
107,056 |
|
- |
|
| Forman Eric |
Secretary |
• – • |
2021-01-04 |
4 |
GA |
$0.00 |
$0 |
D/D |
2,364 |
21,931 |
|
- |
|
| Forman Eric |
Secretary |
• – – |
2020-12-30 |
4 |
GA |
$0.00 |
$0 |
D/D |
2,900 |
19,567 |
|
- |
|
| Ho Hung Tak |
10% Owner |
– – • |
2020-11-30 |
4 |
B |
$4.75 |
$199,999 |
D/D |
42,105 |
0 |
2.45 |
-17% |
|
47 Records found
|
|
Page 1 of 2 |
|
|
